Soleno Therapeutics, Inc. (NasdaqGM: SLNO)
Health Care · Biotechnology · US
$—
— today · — 1Y
Soleno Therapeutics, Inc. (NasdaqGM: SLNO) operates in the Biotechnology industry within the Health Care sector.
trading between 29.43 and 72.99.
Tweenvest scores Soleno Therapeutics, Inc. across four factors: quality 69/100, value 46/100. Its strongest factor is quality.
SLNO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- $285.01M
- P/E
- —
- EPS
- 1.77
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $72.99
- 52-week low
- $29.43
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- 115
- Next earnings
- —
About Soleno Therapeutics, Inc.
Soleno Therapeutics, Inc. (SLNO) operates as a clinical-stage biopharmaceutical company, specializing in the creation and market introduction of groundbreaking treatments for uncommon illnesses. The cornerstone of its therapeutic pipeline is Diazoxide Choline Controlled-Release, a once-daily oral tablet aimed at addressing Prader-Willi Syndrome, currently progressing through an active Phase III clinical evaluation. Established in 1999, the Redwood City, California-headquartered firm adopted its current name, Soleno Therapeutics, Inc., in May 2017, having previously operated as Capnia, Inc.
- ISIN
- US8342033094
- Founded
- 1999
- Listed since
- Nov 13, 2014
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $265.80 | +0.00% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $444.99 | +0.62% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.10 | -0.45% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.50 | -0.06% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $832.63 | -0.11% |
| argenx SEENXTBR: ARGX | $64.17B | €903.40 | +2.75% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $154.84 | -2.51% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.